{
  "slug": "parexel-consulting",
  "name": "Parexel-consulting",
  "description": "Parexel Consulting, a division of Parexel, offers comprehensive clinical development services from Phase I to IV, specializing in oncology trials. They provide regulatory and therapeutic expertise, advanced modeling, patient recruitment, and a global network of sites to accelerate drug development with a patient-first approach.",
  "url": "https://optimly.ai/brand/parexel-consulting",
  "websiteUrl": "https://parexel.com/",
  "logoUrl": "https://logo.clearbit.com/parexel.com",
  "baiScore": null,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "Drug Discovery and Development Services",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-08-27T09:42:24.087Z",
  "verifiedVitals": {
    "website": "https://parexel.com",
    "category": "clinical research organization",
    "what_it_does": "Provides the full range of Phase I to IV clinical development services, leveraging clinical, regulatory, and therapeutic expertise to design and deliver clinical trials in partnership with biopharmaceutical leaders and sites. This includes designing oncology trials, advanced modeling and simulation, application of real-world data, and global regulatory support.",
    "primary_audience": "biopharmaceutical leaders and sites",
    "core_product": "Clinical development services, including clinical trials, regulatory services, and therapeutic expertise",
    "parent_ownership": null,
    "named_competitors": null
  },
  "intentTags": {
    "problemIntents": [
      "Slow clinical trial processes",
      "Difficulty finding suitable patients for trials",
      "Challenges with global regulatory compliance",
      "Inefficient trial design and execution",
      "High costs and resource waste in drug development",
      "Lack of patient insights in trial design",
      "Need for specialized oncology expertise"
    ],
    "solutionIntents": [
      "Accelerate oncology drug development",
      "Improve patient recruitment and retention",
      "Ensure regulatory compliance (FDA, EMA, NMPA, MHRA, PEI)",
      "Optimize clinical trial design with market access in mind",
      "Leverage advanced modeling and simulation for drug effects prediction",
      "Utilize real-world data for patient identification",
      "Employ a patient-first approach in trial execution",
      "Access a global network of clinical trial sites"
    ],
    "evaluationIntents": [
      "Compare CROs for oncology expertise",
      "Assess clinical trial acceleration services",
      "Evaluate regulatory consulting capabilities",
      "Review patient-centric trial design methodologies",
      "Examine global site network reach",
      "Consider real-world data application for trial efficiency"
    ]
  },
  "businessProfileClaims": [],
  "timestamp": 1787922830494
}